News

Filter

Current filters:

SabrilGenito-urinary

1 to 9 of 97577 results

Shire’s Vyvanse first FDA-approved drug for binge eating

31-01-2015

The US Food and Drug Administration on Friday approved UK drugmaker Shire’s Vyvanse (lisdexamfetamine…

NeurologicalPharmaceuticalRegulationShireUSAVyvanse

AbbVie fourth-qtr beats forecasts, but posts Shire-associated $810 million loss

31-01-2015

US drugmaker AbbVie (NYSE: ABBV) on Friday announced financial results for the fourth quarter and full…

AbbVieAnti-Arthritics/RheumaticsAnti-viralsFinancialHumiraPharmaceuticalViekira Pak

Eli Lilly's fourth quarter financials hit by patent expiries and currency issues

Eli Lilly's fourth quarter financials hit by patent expiries and currency issues

30-01-2015

US drugmaker Eli Lilly’s fourth quarter financials were hit by genericization and currency fluctuations,…

CymbaltaEli LillyEvistaFinancialPharmaceutical

Biogen Idec 2014 revenues and earnings rocket

30-01-2015

US biotech major Biogen Idec yesterday reported full-year and fourth quarter 2014 results, showing that…

Biogen IdecBiotechnologyFinancial

Janssen's Prezcobix approved for HIV in the USA

Janssen's Prezcobix approved for HIV in the USA

30-01-2015

The US Food and Drug Administration has approved Prezcobix (darunavir 800mg/cobicistat 150mg) tablets,…

Anti-viralsJanssenPharmaceuticalPrezcobixRegulationUSA

FDA expands approval of Johnson & Johnson/Pharmacyclics' Imbruvica to Waldenstrom’s macroglobulinemia

FDA expands approval of Johnson & Johnson/Pharmacyclics' Imbruvica to Waldenstrom’s macroglobulinemia

30-01-2015

The US Food and Drug Administration has expanded approval of Johnson & Johnson and Pharmacyclics’ Imbruvica…

HematologyImbruvicaJohnson & JohnsonPharmaceuticalPharmacyclicsRegulationUSA

Valeant to serve as “stalking horse bidder” in court-supervised Dendreon sales process

30-01-2015

US biotech firm Dendreon says it has reached an agreement with Canada’s Valeant Pharmaceuticals International…

BiotechnologyDendreonMergers & AcquisitionsOncologyProvengeValeant Pharmaceuticals International

CMOs must offer meaningful value to take advantage of biosimilars trend, says report

30-01-2015

If contract manufacturing organizations are to take advantage of the wave of interest in biosimilars,…

BiosimilarsBiotechnologyComputer hardwareLicensingPharmSourceProduction

1 to 9 of 97577 results

Back to top